Angiotensin receptor blocker (ARB)
Ambulatory blood pressure response to triple therapy with an angiotensin-receptor blocker (ARB), calcium-channel blocker (CCB), and HCTZ versus dual therapy with an ARB and HCTZ
... dose triple-therapy combinations (valsartan/amlodipine/ HCTZ 320/10/25 mg or olmesartan/amlodipine/HCTZ 40/10/25 mg) lowered 24-hour, nighttime, and daytime ABP significantly more effectively than any dual-therapy ...
8
The role of neurohormonal blockers in the primary prevention of acute-, early-, and late-onset anthracycline-induced cardiotoxicity
... ACEI: Angiotensin-converting enzyme inhibitor; AIC: Anthracycline-induced cardiotoxicity; ARB: Angiotensin receptor blocker; ASCO: American Society of Clinical Oncology; ...
7
High visceral fat with low subcutaneous fat accumulation as a determinant of atherosclerosis in patients with type 2 diabetes
... ACEI: angiotensin-converting enzyme inhibitor; ACR: albumin-to-creatinine ratio; ALT: alanine aminotransferase; ARB: angiotensin receptor blocker; AST: asparatate aminotransferase; BMI: ...
7
Effects of the SGLT2 inhibitor dapagliflozin on HDL cholesterol, particle size, and cholesterol efflux capacity in patients with type 2 diabetes: a randomized placebo-controlled trial
... ACEi: angiotensin converting enzyme inhibitors; ACR: albumin creatinine ratio; ARB: angiotensin receptor blocker; ARE: arylesterase; AU: arbitrary unit; BIA: bioelectrical impedance ...
10
Utility of untimed single urine protein/creatinine ratio as a substitute for 24 h proteinuria for assessment of proteinuria in systemic lupus erythematosus
... ACE: Angiotensin-converting enzyme; ACR: American College of Rheumatology; ARB: Angiotensin receptor blocker; CCC: Concordance correlation coefficient; CI: Confidence interval; ExC: ...
9
Irbesartan improves arterial compliance more than lisinopril
... The purpose of this study was to assess the effect of an angiotensin receptor blocker (ARB), irbesartan, and an ACE inhibitor (ACEI), lisinopril, on arterial compliance[r] ...
6
A systematic review of the predictors of disease progression in patients with autosomal dominant polycystic kidney disease
... ACEI angiotensin-converting enzyme inhibitor, ADPKD autosomal dominant polycystic kidney disease, Alb/Cr albumin/creatinine ratio, ARB angiotensin receptor blocker, BL baseline, BMI ...
16
Peripheral arterial endothelial dysfunction predicts future cardiovascular events in diabetic patients with albuminuria: a prospective cohort study
... ACEI: Angiotensin‑converting enzyme inhibitor; ARB: Angiotensin receptor blocker; ASCVD: Atherosclerotic cardio‑ vascular disease; CAC : Coronary artery calcification; CAD: Coronary ...
10
Aliskiren and valsartan combination therapy for the management of hypertension
... an angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) confers some cardiorenal protection; however, these agents do not extinguish the RAAS as evidenced ...
12
Hypertension and blood pressure variability management practices among physicians in Singapore
... ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; BB, beta-blocker; BP, blood pressure; BPV, BP variability; CCB, calcium channel blocker; ...
11
Mechanisms of endothelial dysfunction in rheumatoid arthritis: lessons from animal studies
... Abbreviations ACE: Angiotensin-converting enzyme; ACh: Acetylcholine; AIA: Adjuvantinduced arthritis; ANG-II: Angiotensin II; ARB: Angiotensin receptor blocker; BH4: Tetrahydrobiopterin;[r] ...
8
Assessment of the LDL-C/HDL-C ratio as a predictor of one year clinical outcomes in patients with acute coronary syndromes after percutaneous coronary intervention and drug-eluting stent implantation
... ACEI: Angiotensin-converting enzymeinhibitor; ACS: Acute coronary syndromes; AMI: Acute myocardial infarction; ARB: Angiotensin receptor blocker; BP: Blood pressure; CABG: Coronary ...
8
The impact of DPP-4 inhibitors on long-term survival among diabetic patients after first acute myocardial infarction
... ACEI: angiotensin‑converting enzyme inhibitor; ACS: acute coronary syn‑ drome; AMI: acute myocardial infarction; ARB: angiotensin receptor blocker; CAROLINA: cardiovascular outcome ...
11
Action to Support Practices Implement Research Evidence (ASPIRE) : protocol for a cluster randomised evaluation of adaptable implementation packages targeting 'high impact' clinical practice recommendations in general practice
... PDF 262 kb Abbreviations ACE-I: angiotensin-converting-enzyme inhibitor; ACR: albumin to creatinine ratio; ARB: angiotensin receptor blocker; ASPIRE: Action to Support Practices Implemen[r] ...
11
Global longitudinal strain is a more reproducible measure of left ventricular function than ejection fraction regardless of echocardiographic training
... ACE: Angiotensin converting enzyme; ACS: Acute coronary syndrome; AHA: American Heart Association; ARB: Angiotensin receptor blocker; CMR: Cardiovascular magnetic resonance imaging; ...
12
Concomitant use of renin-angiotensin-aldosterone system inhibitors prevent trastuzumab-induced cardiotoxicity in HER2+ breast cancer patients: an institutional retrospective study
... ACE-I: Angiotensin converting enzyme inhibitor; AJCC: American Joint Committee on Cancer; AngII: Angiotensin II; ARB: Angiotensin receptor blocker; BB: Beta blocker; BMI: ...
9
Management of anticoagulation and antiplatelet therapy in patients with primary membranous nephropathy
... ACEI/ARB: angiotensin converting enzyme inhibitor/angiotensin receptor blocker; ACS: acute coronary syndrome; AF: atrial fibrillation; ATE: arterial thromboembolic event; ATRIA: ...
11
Long-term clinical outcome of patients with severe atherosclerotic renal artery stenosis after percutaneous transluminal renal angioplasty
... ingested ARB or ACEi before ...RAS blocker, therefore both renal is- chemia and renal function might be improved by ...RAS blocker might not have caused further renal ...
9
Developing a multi-center clinical data mart of ACEI and ARB for real-world evidence (RWE)
... RWE is already recognized as a novel clinical research method, and its influence is enormous. However, it does not challenge to the strengths of RCT, and instead may be valued as a study preceding RCT. RCT and RWE are ...
7
Urinary angiotensinogen level is associated with potassium homeostasis and clinical outcome in patients with polycystic kidney disease: a prospective cohort study
... (K > 5.5) (Fig. 3). The lower prevalence of hyperkalemia in PKD was prominent in the early CKD stages, and attenuated with decline of renal function. In the multivari- able logistic regression analysis, we built up ...
12